← back to search

Nina Lin

Boston University · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV-related health complications and treatments, HIV/AIDS drug development and treatment, and HIV/AIDS Research and Interventions.
h-index
20
citations
3,675
works
58
NIH funding
primary concept
Medicine
email

Recent publications

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
JAMA 2021cited by 718position: middledoi
Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta‐Analysis
Journal of the American Heart Association 2021cited by 40position: middledoi
Intragenic proviral elements support transcription of defective HIV-1 proviruses
PLoS Pathogens 2021cited by 20position: middledoi
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
International Journal of Infectious Diseases 2020cited by 67position: middledoi
HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation
The Journal of Infectious Diseases 2020cited by 34position: middledoi
Heart Failure Outcomes and Associated Factors Among Veterans With Human Immunodeficiency Virus Infection
JACC Heart Failure 2020cited by 20position: middledoi
Infectious Myelitis
Seminars in Neurology 2019cited by 23position: middledoi
HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility
Journal of Virology 2019cited by 18position: middledoi
Aging, immune senescence, and immunotherapy: A comprehensive review
Seminars in Oncology 2018cited by 92position: middledoi
Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
Frontiers in Immunology 2018cited by 40position: middledoi
Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study
The Lancet HIV 2017cited by 115position: middledoi
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants
EBioMedicine 2016cited by 25position: firstdoi
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
The Journal of Infectious Diseases 2013cited by 263position: middledoi
A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
The Journal of Infectious Diseases 2012cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Manish Sagar · Boston University5 papers (2013–2020)Jennifer Snyder‐Cappione · Boston University3 papers (2018–2020)Alex Olson · Boston University3 papers (2018–2021)Ludy Registre · Boston University2 papers (2016–2019)Timothy J. Henrich · World Wide Web Consortium2 papers (2013–2019)Wen‐Chih Wu · Brown University2 papers (2020–2021)Daniel R. Kuritzkes · Brigham and Women's Hospital2 papers (2013–2016)Sebhat Erqou · Brown University2 papers (2020–2021)Carolyn Coote · Boston University2 papers (2020–2021)Anna C. Belkina · Boston University1 papers (2018–2018)Michelle Lally · Brown University1 papers (2020–2020)Gaurav Choudhary · Technical University of Denmark1 papers (2020–2020)Heather J. Ribaudo · Cancer Research And Biostatistics1 papers (2012–2012)Lawrence K. Fox · National Institute of Allergy and Infectious Diseases1 papers (2012–2012)Amjad Samara · University of Arkansas for Medical Sciences1 papers (2021–2021) · 1 papers (2012–2012)Timothy Wilkin · Weill Cornell Medicine1 papers (2012–2012)Alan Landay · Rush University Medical Center1 papers (2012–2012)Bruce D. Walker · Active Technologies (Italy)1 papers (2017–2017) · 1 papers (2021–2021)